• Investing Ideas
  • /
  • Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies
33 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TECN

Tecan Group
CHF365.603.3%-5.3%CHF4.7bCHF392.57PE35.4xE9.6%0.8%

MOR

MorphoSys
€102.000%0%€2.5b€80.22PE27.3xE14.1%n/a

907582

Amgen
US$226.360%n/aUS$145.8bUS$229.35PE19.3xE5.7%3.1%

0QF

Moderna
US$184.330%40.6%US$53.4bUS$293.47PE6.4xE-15.5%n/a

UNC

UCB
€77.910%n/a€16.3b€87.27PE38.8xE24.8%1.5%

BAYN

Bayer
€190.000%-5.0%€25.9b€281.79PB0.8xE43.2%0.4%

982352

AstraZeneca
UK£116.681.5%-3.6%UK£161.8bUK£140.62PE34.8xE16.6%2.1%

SFZN

Siegfried Holding
CHF916.00-1.5%42.0%CHF3.9bCHF993.55PE34.5xE14.5%0.4%

MER

Merck KGaA
€228.300%n/a€69.6b€256.49PE24.6xE9.6%1.4%
Page 2 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.